Infigratinib is not FDA-, Health Canada- or Therapeutics Goods Association-approved for any other indication
Bortezomib for injection is used to treat certain types of cancer such as multiple myeloma and mantle cell lymphoma
The announcement follows FDA 510(k) clearance of device
As a global mushroom biotechnology group, Mycelium Biotechnology is engaged in mushroom growing, global distribution and offering biotechnology and nutraceutical solutions through global partners
Three RFPs now open for qualified researchers through NORD's Jayne Holtzer rare disease research grants program
The companies expect to complete the submission of the NDA for treatment of MDD in the second half of 2022; associated filing for postpartum depression is anticipated in the first half of 2023
Pharma exports in 2021-22 sustain a positive growth despite global trade disruptions
Ultomiris showed early effect and lasting improvement in activities of daily living and has potential to reduce treatment burden with dosing every 8 weeks
To extend the nationwide distribution network for the availability of its proprietary & award-winning HPod for corporates & doctors’ clinics, thereby strengthening India’s phygital wellness ecosystem
First approved therapy in Europe for the treatment of chronic kidney disease (CKD)-associated pruritus in hemodialysis patients
Subscribe To Our Newsletter & Stay Updated
